Daxxify lasts approximately 6 months per treatment, compared to Botox's typical 3–4 month duration. This longer interval is Daxxify's primary clinical advantage—and the key driver of patient interest. However, duration alone doesn't determine which product fits your practice or your patients' needs.
Duration: The Core Difference
Daxxify (daxibotulinum toxin-A) received FDA approval in 2023 and is formulated with a peptide that extends neuromuscular blockade. Clinical trials showed median duration of 6 months, with some patients reporting results at 6+ months. Botox (onabotulinumtoxinA) remains the gold standard at 3–4 months, though individual variation is common in both.
For practices, the longer interval means fewer appointments per year—potentially reducing chair time and scheduling pressure, but also reducing annual visit frequency and revenue per patient.
Cost Tradeoffs
Daxxify's per-unit wholesale cost is higher than Botox, typically 20–40% more depending on your supplier and volume. Because duration is longer, total annual cost to the patient may be comparable or slightly higher, but the math varies:
Bottom line: Choose Daxxify for convenience-seeking, established patients willing to pay premium pricing; choose Botox for first-timers, budget-conscious patients, and practices optimizing for visit frequency and volume.
Daxxify lasts 6 months vs Botox's 3–4, but higher per-unit cost means annual patient spend is often comparable—the real win is convenience and scheduling efficiency.
Patient Fit & Practice Angle
Ideal Daxxify candidates:
Patients seeking convenience and fewer appointments
Those with stable, predictable response to neuromodulators
Patients willing to pay a premium for longer intervals
Those with variable metabolism or unpredictable results
Patients on tight budgets
Practices optimizing for frequent, high-volume visits
The Bottom Line
Neither product is universally "better"—it's about patient goals, budget, and your practice model. Many successful practices offer both, letting patients choose. Daxxify attracts a subset of loyal, convenience-focused patients; Botox remains the volume and entry-level workhorse.
Track your own patient retention, satisfaction, and revenue per patient on each product. Your data will guide inventory and marketing decisions far better than duration claims alone.
Frequently asked questions
How long does Daxxify last compared to Botox?
Daxxify lasts approximately 6 months per treatment, while Botox typically lasts 3–4 months. Daxxify received FDA approval in 2023 and uses a peptide formulation that extends neuromuscular blockade, though individual variation is common in both products.
Is Daxxify more expensive than Botox per unit?
Yes, Daxxify's per-unit wholesale cost is typically 20–40% higher than Botox depending on your supplier and volume. However, because patients need fewer treatments per year (2 vs. 4), total annual cost to the patient is often comparable or only modestly higher.
Should I offer Daxxify or Botox in my med spa?
Many successful practices offer both products. Daxxify works best for convenience-focused, loyal patients willing to pay a premium for fewer appointments, while Botox remains ideal for first-time patients, budget-conscious clients, and high-volume practice models. Track your own patient retention and revenue per patient to guide inventory decisions.
Who is the ideal candidate for Daxxify treatment?
Ideal Daxxify candidates are patients seeking convenience and fewer appointments, those with stable and predictable response to neuromodulators, patients willing to pay a premium for longer intervals, and practices with longer booking windows. First-time patients or those with variable metabolism typically benefit more from Botox's shorter commitment.
How many appointments per year do Daxxify vs Botox patients need?
Botox patients typically need 4 treatments per year, while Daxxify patients need approximately 2 treatments per year. This means fewer chair appointments for Daxxify patients, which reduces scheduling pressure but also lowers annual visit frequency and revenue per patient.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief every morning. The owners who read it never get blindsided.
